All In MedTech

FDA Clearance Tracker · P210017

Cross-Seal Suture-Mediated Vascular Closure Device System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Sep 26, 2023 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Sep 26, 2023

Approved

Time to decision

880 days

Received Apr 29, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P210017
Device name
Cross-Seal Suture-Mediated Vascular Closure Device System
Applicant location
Somerset, NJ
Received
Apr 29, 2021
Decided
Sep 26, 2023
Decision
Approved

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MGB

FDA's approval statement

As written in FDA's record.

Approval for the Cross-Seal Suture-Mediated Vascular Closure Device System. The device is indicated for the percutaneous delivery of sutures for closing the common femoral artery access site while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional catheterization procedures using 8F to 18F sheaths. The Cross-Seal System is indicated for one access site per leg.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MGB. The earliest in FDA's data is P920004, decided Sep 29, 1995.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Terumo Medical Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.